Annual CAPEX
$12.00 K
-$431.20 K-97.29%
30 September 2024
Summary:
Sonnet BioTherapeutics Holdings annual capital expenditures is currently $12.00 thousand, with the most recent change of -$431.20 thousand (-97.29%) on 30 September 2024. During the last 3 years, it has risen by +$8400.00 (+233.33%). SONN annual CAPEX is now -98.52% below its all-time high of $810.20 thousand, reached on 30 September 2022.SONN CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
N/A
30 September 2024
Summary:
Sonnet BioTherapeutics Holdings quarterly capital expenditures is not available.SONN Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
N/A
30 September 2024
Summary:
Sonnet BioTherapeutics Holdings TTM capital expenditures is not available.SONN TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SONN CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -97.3% | - | - |
| 3 y3 years | +233.3% | - | - |
| 5 y5 years | - | - | - |
SONN CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -98.5% | +233.3% | ||||
| 5 y | 5 years | -98.5% | +233.3% | ||||
| alltime | all time | -98.5% | +233.3% |
Sonnet BioTherapeutics Holdings CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | $12.00 K(-97.3%) | - | - |
| Sept 2023 | $443.20 K(-45.3%) | $170.00 K(+1316.7%) | $443.20 K(+109.5%) |
| June 2023 | - | $12.00 K(-95.4%) | $211.60 K(-73.1%) |
| Mar 2023 | - | $261.20 K(-524.0%) | $785.90 K(-3.0%) |
| Sept 2022 | $810.20 K | -$61.60 K(-110.5%) | $810.30 K(-7.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | $586.30 K(+254.0%) | $871.90 K(+205.3%) |
| Mar 2022 | - | $165.60 K(+38.0%) | $285.60 K(+138.0%) |
| Dec 2021 | - | $120.00 K(+509.1%) | $120.00 K(+509.1%) |
| Sept 2021 | $3600.00 | - | - |
| Mar 2020 | - | $19.70 K | $19.70 K |
FAQ
- What is Sonnet BioTherapeutics Holdings annual capital expenditures?
- What is the all time high annual CAPEX for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings annual CAPEX year-on-year change?
- What is the all time high quarterly CAPEX for Sonnet BioTherapeutics Holdings?
- What is the all time high TTM CAPEX for Sonnet BioTherapeutics Holdings?
What is Sonnet BioTherapeutics Holdings annual capital expenditures?
The current annual CAPEX of SONN is $12.00 K
What is the all time high annual CAPEX for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high annual capital expenditures is $810.20 K
What is Sonnet BioTherapeutics Holdings annual CAPEX year-on-year change?
Over the past year, SONN annual capital expenditures has changed by -$431.20 K (-97.29%)
What is the all time high quarterly CAPEX for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high quarterly capital expenditures is $586.30 K
What is the all time high TTM CAPEX for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high TTM capital expenditures is $871.90 K